Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Gains from Sales and Divestitures (2016 - 2024)

Historic Gains from Sales and Divestitures for Innoviva (INVA) over the last 16 years, with Q4 2024 value amounting to $241000.0.

  • Innoviva's Gains from Sales and Divestitures fell 1514.08% to $241000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $241000.0, marking a year-over-year decrease of 1514.08%. This contributed to the annual value of $241000.0 for FY2024, which is 1514.08% down from last year.
  • Innoviva's Gains from Sales and Divestitures amounted to $241000.0 in Q4 2024, which was down 1514.08% from $284000.0 recorded in Q4 2023.
  • Innoviva's Gains from Sales and Divestitures' 5-year high stood at $284000.0 during Q4 2023, with a 5-year trough of $86.0 in Q4 2021.
  • Moreover, its 5-year median value for Gains from Sales and Divestitures was $233000.0 (2022), whereas its average is $170417.2.
  • As far as peak fluctuations go, Innoviva's Gains from Sales and Divestitures crashed by 9990.85% in 2021, and later soared by 27083023.26% in 2022.
  • Over the past 5 years, Innoviva's Gains from Sales and Divestitures (Quarter) stood at $94000.0 in 2020, then tumbled by 99.91% to $86.0 in 2021, then surged by 270830.23% to $233000.0 in 2022, then grew by 21.89% to $284000.0 in 2023, then decreased by 15.14% to $241000.0 in 2024.
  • Its Gains from Sales and Divestitures stands at $241000.0 for Q4 2024, versus $284000.0 for Q4 2023 and $233000.0 for Q4 2022.